reviewThe Lancet OncologyMar 1, 2019Closed access

Immunotherapy and targeted therapy combinations in metastatic breast cancer

NYU Langone Health · Yale Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

466
total citations
FWCI
48.90
Percentile
100%
References
87
Citations per year

Authors

4

Topics & keywords

Keywords
  • Metastatic breast cancer
  • Immunotherapy
  • Medicine
  • Breast cancer
  • Oncology
  • Targeted therapy
  • Internal medicine
  • Cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding